Correction to: Nature Biotechnology https://doi.org/10.1038/s41587-021-00980-x, published online 22 June 2021.
In the version of this article initially published online, the name of the company Vir Biotechnology was given as Vir Therapeutics. The error has been corrected in the print, PDF and HTML versions of the article.
About this article
Cite this article
Dolgin, E. Publisher Correction: ‘Super-antibodies’ could curb COVID-19 and help avert future pandemics. Nat Biotechnol 39, 893 (2021). https://doi.org/10.1038/s41587-021-00997-2